Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
Thorsten P. Degenhardt(University of South Carolina), John Baynes(Dartmouth College), David D. Arrington(University of Minnesota), Robert J. Beattie(University of Minnesota), John M. Basgen(University of Minnesota), Michael W. Steffes(Tufts University), Suzanne R. Thorpe(University of South Carolina), Nathan L. Alderson(University of South Carolina)
Cited by 377
Related Papers
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k
Role of Oxidative Stress in Development of Complications in Diabetes
|Diabetes|1991|3.7k
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
|Diabetes|1999|2.4k
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products
|Journal of Biological Chemistry|2000|957
Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.
|Journal of Biological Chemistry|1986|849